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The crystal structure of the DNA-damage checkpoint
inhibitor of sporulation, Sda, from Bacillus subtilis, has been
solved by the MAD technique using selenomethionine-
substituted protein. The structure closely resembles that
previously solved by NMR, as well as the structure of a
homologue from Geobacillus stearothermophilus solved in
complex with the histidine kinase KinB. The structure contains
three molecules in the asymmetric unit. The unusual trimeric
arrangement, which lacks simple internal symmetry, appears
to be preserved in solution based on an essentially ideal fit to
previously acquired scattering data for Sda in solution. This
interpretation contradicts previous findings that Sda was
monomeric or dimeric in solution. This study demonstrates the
difficulties that can be associated with the characterization of
small proteins and the value of combining multiple biophysical
techniques. It also emphasizes the importance of under-
standing the physical principles behind these techniques and
therefore their limitations.
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1. Introduction
The signal transduction pathway directing sporulation in
Bacillus subtilis is primarily triggered by the sensor histidine
kinase KinA (Trach & Hoch, 1993). In response to an as yet
unknown cue, KinA utilizes ATP to autophosphorylate at a
conserved histidine residue. The phosphate moiety is then
sequentially passed via two other proteins, Spo0F and Spo0B,
to the master sporulation transcription factor Spo0A, which
directly or indirectly influences hundreds of genes involved in
sporulation (Piggot & Hilbert, 2004). Various checkpoints
exist to ensure that sporulation onset is not triggered in-
appropriately. One of these checkpoints involves the Sda
protein. The gene for Sda was originally identified as the focus
of mutations that permitted sporulation in strains that are
ordinarily incapable of sporulating owing to defects in the
DNA-replication initiation protein DnaA (hence, suppressor
of dnaA; Burkholder et al., 2001).
Sda was shown to bind to KinA and to inhibit its function
(Burkholder et al., 2001) and the structure of this small
46-amino-acid protein from B. subtilis was solved by NMR
(Rowland et al., 2004). Sda was predicted to bind the KinA
dimer near the hinge regions connecting the catalytic and
ATP-binding (CA) domains to the four-helix bundle dimer-
ization and histidine phosphotransfer (DHp) domain. Its
inhibitory function was proposed to result from bound Sda
impeding the CA-domain movement required to access the
target histidine residues on the DHp ‘stalk’ (Rowland et al.,
2004). This hypothesis was contradicted by a model derived
from small-angle X-ray (SAXS) and neutron (SANS) scat-
tering data that showed Sda molecules bound to either side of
the DHp stalk at the end distal to that linking the DHp and
CA domains (Whitten et al., 2007). An otherwise unrelated
inhibitor of KinA, KipI, was shown to bind this same surface
of the DHp domain (Jacques et al., 2008). Our KinA–Sda
model, in which the Sda molecules do not directly contact the
CA domains, was subsequently confirmed by genetic and
biochemical methods (Cunningham & Burkholder, 2009) and
by a recent cocrystal structure of the related Geobacillus
stearothermophilus Sda (Gst-Sda) bound to a homologous
kinase, KinB (Bick et al., 2009). In this communication, we
report the crystal structure of Sda from B. subtilis (Bsu-Sda),
which crystallizes with three Sda molecules in the asymmetric
unit. We discuss this structure in relation to both the NMR-
derived structure of Bsu-Sda (Rowland et al., 2004) and the
KinB–Sda structure from G. stearothermophilus (Gst-Sda;
Bick et al., 2009) and in relation to a re-evaluation of
previously reported small-angle X-ray scattering data
(Whitten et al., 2007).
2. Methods
2.1. Protein expression, purification and crystallization
Bsu-Sda was expressed as a GST fusion from pSLR65
(Rowland et al., 2004) within an Escherichia coli BL21 (DE3)
host and purified as previously described (Whitten et al.,
2007). Selenomethionyl labelling was performed using the
Overnight Express Autoinduction System 2 (Novagen).
Cleavage of the purified protein with thrombin released an
Sda protein 48 residues in length comprising the 46 residues of
Sda attached to two additional N-terminal residues (GS;
confirmed by whole-protein mass spectrometry). Crystals of
Sda were obtained by the hanging-drop vapour-diffusion
method, in which 2 ml protein solution [7.8 mg ml1 in 50 mM
tris(hydroxymethyl)aminomethane pH 8.5, 200 mM NaCl]
was mixed with 2 ml reservoir solution [15% polyethylene
glycol 5000 monomethyl ether, 0.1M 2-(N-morpholino)-
ethanesulfonic acid pH 6.3] and trays were incubated at 293 K.
The crystal was cryoprotected by dipping it for a few seconds
in reservoir solution doped with 2-methyl-2,4-pentanediol
[20%(v/v)] before flash-cooling in a cold nitrogen stream
(100 K; Oxford Cryostream).
2.2. Data collection and processing
Diffraction data were recorded at 100 K at three wave-
lengths corresponding to the peak ( = 0.97945 A˚), the
inflection point ( = 0.97959 A˚) and a high-energy remote
( = 0.94945 A˚) of a selenium K-edge absorption profile on
beamline 23ID-D at the Advanced
Photon Source (Argonne, USA) using a
MAR300 CCD detector. The data were
integrated and scaled with HKL-2000
(Otwinowski & Minor, 1997).
2.3. Structure solution and refinement
Initial attempts to solve the structure
of the native crystals by molecular
replacement using the NMR structure
as the search model were unsuccessful,
possibly owing to our expectation that
there would be two molecules in the
asymmetric unit. This assumption was
supported by the calculation of a
Matthews coefficient (Matthews, 1968),
which yielded a reasonable solvent
content of 54% for two molecules per
asymmetric unit, and by small-angle
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Figure 1
Sda amino-acid sequences. (a) Sequence homology between Sda from B. subtilis (Bsu) and
G. stearothermophilus (Gst). Helical segments are indicated. C-terminal residues absent in either
crystal structure are coloured grey. (b) Residues refined in the three molecules found in the
asymmetric unit of Bsu-Sda and in the NMR ensemble (PDB entry 1pv0). The side chains of the
residues indicated by blue text are represented by poor electron density and therefore were not
modelled in the crystal structure, nor were they refined to unique positions in the NMR ensemble.
Residues in light blue text were not refined to unique positions in the NMR ensemble.
Table 1
Data-collection and refinement statistics.
(a) Data collection for selenomethionine Sda crystal in space group P41212.
Values in parentheses are for the highest resolution shell.
Peak Inflection Remote
Wavelength (A˚) 0.97945 0.97959 0.94945
Unit-cell parameters (A˚) a = b = 37.0,
c = 167.2
a = b = 37.0,
c = 167.3
a = b = 37.0,
c = 167.3
Resolution limits (A˚) 50–1.97 50–1.97 50–1.91
Completeness (%) 99.5 (99.9) 99.5 (99.4) 99.2 (98.9)
Unique reflections† 15638 15608 17072
Redundancy 3.6 (3.1) 3.6 (3.1) 3.4 (3.0)
Rmerge‡ 0.060 (0.56) 0.059 (0.62) 0.056 (0.94)
Average I/(I) 16.4 (2.19) 16.8 (2.15) 17.5 (1.56)
Wilson B value (A˚2) 32.6 33.7 34.2
(b) Refinement statistics on peak data.
Non-H atoms 888
Water molecules 8
R.m.s.d. bond lengths (A˚) 0.010
R.m.s.d. bond angles () 1.1
R.m.s.d. peptide planarity () 4.2
Ramachandran plot favoured (%) 98.1
Ramachandran plot accepted (%) 2
Ramachandran plot outliers (%) 0
Mean B value (A˚2) 29.9
R.m.s.d. B, main chain (A˚2) 2.0




X-ray scattering (SAXS) data that we had interpreted as
indicating that Sda was a dimer in solution (Whitten et al.,
2007) rather than a monomer as reported previously based on
NMR and multiple-angle laser light-scattering (MALLS) data
(Rowland et al., 2004). Initial calculations with SOLVE
(Terwilliger, 2003) using the three-wavelength diffraction data
clearly identified five anomalous difference Patterson peaks in
space group P41212 rather than the four peaks expected for a
dimer (each Sda contains two selenomethionine residues).
Solvent flattening and density modification using RESOLVE
(Terwilliger, 2003) yielded easily traceable maps that clearly
revealed three molecules of Sda per asymmetric unit (solvent
content28%), one of which was missing N-terminal residues
including the N-terminal selenomethionine (see Fig. 1).
Manual map inspection and model building were performed
with Coot (Emsley & Cowtan, 2004) and positional refinement
was performed with REFMAC5 (Murshudov et al., 1997).
Structure validation, including Ramachandran analysis
(Table 1), was performed withMolProbity (Lovell et al., 2003).
The calculation of contact surface areas between molecules
was performed with PISA (Krissinel &
Henrick, 2007). Images were prepared with
PyMOL (http://www.pymol.org).
2.4. Mass spectrometry
Sda molecules were released from a
crystal which was briefly washed in
trifluoroacetic acid (0.1%) before being
dissolved in water (6 ml). Whole-protein
mass spectrometry was then performed as
described previously (Whitten et al., 2007).
2.5. Small-angle X-ray scattering analysis
The SAXS data re-evaluated in this study
are those reported by Whitten et al. (2007).
Briefly, SAXS data on Sda and its buffer
(2 and 6 h exposures, respectively) were
collected at 293 K on a Bruker Nanostar
instrument with three-pinhole collimation.
Sda monomer, dimer, trimer, tetramer and
hexamer atomic models were evaluated
against the SAXS data using the program
CRYSOL (Svergun et al., 1995). Ab initio
shape-restoration calculations were per-
formed using DAMMIN (Svergun, 1999)
with P1 symmetry and the resultant dummy-
atom models were averaged and filtered
using DAMAVER (Volkov & Svergun,
2003) with the default parameters. The
average normalized spatial discrepancy
value for the 12 DAMMIN calculations
performed was 0.46, with a standard devia-
tion of 0.01, indicating that the solutions are
highly consistent. Alignment of atomic
models with the averaged and filtered model
from DAMAVER was optimized using
SUPCOMB13 (Kozin & Svergun, 2001). The
volume of the models was calculated using
NUCPROT (Voss & Gerstein, 2005). The
possibility that multiple oligomers were
present in solution was assessed using
OLIGOMER (Konarev et al., 2003).
2.6. Multiple-angle laser light scattering
MALLS was performed on samples
eluting from a Pharmacia HR 10/30
research papers
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Figure 2
Sda crystal and NMR structures. (a) The C traces of the three subunits of the asymmetric unit
(A, green; B, light blue; C, magenta) are superposed with each other and with well ordered
residues of model A of the NMR structure (red) andGst-Sda from the Gst-Sda–KinB complex
(grey). The side of the molecule which interacts with the histidine kinase is indicated by residue
Phe25 from Gst-Sda (grey sticks). (b) Stick representation of Bsu-Sda (chain A, green
backbone) superposed with Gst-Sda (grey). Residues which form a hydrophobic surface
centred on Phe25 are labelled (Bsu-Sda sequence). (c) Superposition of the interaction
surfaces formed between Gst-Sda and Gst-KinB (yellow and orange, respectively), Bsu-Sda
chains C and B (magenta and light blue, respectively) and Bsu-Sda chains B and A* (pink and
blue, respectively). Residues that form a hydrophobic pocket for Phe25 of Sda are labelled
(those in parentheses are the analogous residues from Gst–KinB; orange).
Superdex 75 column pumped by an A¨KTAHPLC (Amersham
Pharmacia Biotech) at 0.5 ml min1 in either ‘original’ buffer
(50 mM sodium phosphate pH 7.9, 300 mM NaCl, 0.02%
NaN3; Rowland et al., 2004) or SAXS buffer (50 mM Tris pH
8.5, 50 mM NaCl; Whitten et al., 2007). The column eluate was
plumbed into a miniDAWN Tristar laser light-scattering
photometer and then into an Optilab DSP interferometric
refractometer (both from Wyatt Technology Corporation).
Samples were loaded onto the column via a 1 ml loop. Sda was
loaded at 2 mg ml1 (injections of 0.5 and 0.05 ml). Bovine
pancreatic trypsin inhibitor (BPTI; Roche) was loaded at
1 mg ml1 (0.5 ml injection). Sda samples were dialysed in the
appropriate column buffer prior to injection. Molecular-
weight estimates were determined using Debye fitting and
reported errors are standard deviations on the molecular-
weight estimates.
3. Results and discussion
3.1. Sda structure solution and comparison with NMR
ensemble
The crystal structure of selenomethionine-substituted Bsu-
Sda was solved by the MAD method and comprised three
molecules per asymmetric unit. The residues modelled are
presented in Fig. 1(b), where those in blue text represent
residues for which insufficient electron density resulted in side
chains being truncated to their C atoms. The relatively large
gulf between the R and Rfree crystal structure-quality indica-
tors (Table 1) might reflect the fact that only 79% of residues
could be resolved for the three molecules and of these 20%
were not modelled beyond atom C (that is, only 75% of
nonsolvent electrons have been modelled). Whole-protein
mass spectrometry of a washed and redissolved crystal gave a
single peak at m/z = 5690 (corresponding to the expected
molecular weight), confirming the predominance of molecules
comprising all 48 residues in the crystal (data not shown). We
can therefore attribute the absence of electron density to
structural disorder rather than proteolysis. The three Bsu-Sda
molecules of the asymmetric unit all share the same basic
antiparallel helical hairpin fold (Fig. 2a); overlaying the C
backbones yielded root-mean-square deviations (r.m.s.d.s) of
0.53, 0.51 and 0.73 A˚ for the superposition of molecules A on
B, A on C and B on C (for 37, 35 and 35 aligned C atoms),
respectively. This fold is also essentially the same as that
observed for the NMR ensemble of Bsu-Sda (PDB code 1pv0;
Rowland et al., 2004); the first of 25 calculated structures (the
C atoms of which closely overlay each other) superpose on
chains A, B and C of the crystal structure with r.m.s.d.s of 0.73,
0.72 and 0.94 A˚ (for 33, 33 and 37 aligned C atoms),
respectively. The residues of the NMR ensemble for which
side chains are ill-defined largely correlate with those that are
also poorly defined in the electron density (Fig. 1b, blue text)
and those C-terminal residues that the ensemble suggests are
disordered (Fig. 1b, light blue text) are absent in the crystal
structures.
3.2. Comparison with homologue from
G. stearothermophilus
The Bsu-Sda crystal structure is also very similar to that of
the Sda molecule cocrystallized in complex with KinB from
G. stearothermophilus (Gst-Sda; PDB code 3d36; Bick et al.,
2009; Fig. 2a). This structural homology is unsurprising given
that 33 of the 46 residues (72%) are identical in Sda from the
two species (Fig. 1a). Gst-Sda superposes onto the A, B and C
chains of Bsu-Sda with r.m.s.d.s of 0.38, 0.67 and 0.62 A˚ (for
37, 37 and 39 aligned C atoms), respectively. The extreme
N-terminal residues of Bsu-Sda (which are disordered in the
NMR structure) fold back onto one surface of the helical
hairpin as in Gst-Sda, where in the Sda–KinB complex they
contribute to the interaction with KinB. A superposition of the
residues from the two organisms which comprise this hydro-
phobic surface centred about the invariant Phe25 is shown in
Fig. 2(b). The extreme C-terminal residues of the C chain of
Bsu-Sda, as in the NMR structure and in Gst-Sda, fold back
onto the other surface of the hairpin where they project away
from the DHp domain in the Gst-Sda–KinB complex.
Equivalent C-terminal folds are not possible in the A and B
chains of Bsu-Sda owing to steric clashes with symmetry-
related molecules (see below).
3.3. Sda arrangement in the crystal
On cursory inspection, the three molecules in the asym-
metric unit pack against each other in an unusual arrangement
unrelated by simple rotation about twofold or threefold axes
(Fig. 3). However, the generation of symmetry-related mole-
cules by rotation about a crystallographic twofold axis reveals
a tightly packed arrangement of six molecules (chains A, B, C,
A*, B* and C* in Fig. 3). The disordered C-termini of these
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Figure 3
Arrangement of Sda molecules in the crystal. Molecules A, B and C
constitute the asymmetric unit. The residue number for the terminus of
each chain modelled is indicated. Molecules A*, B* and C* are related to
the asymmetric unit by rotation about a twofold crystal symmetry axis
(perpendicular to the middle of the image).
units are located on the periphery of this ensemble, where they
make no obvious contribution to intermolecular packing.
When the surface areas of contact are calculated between the
different pairs of this ensemble, two significant surfaces of
interaction are evident: that between molecules B and C and
that between molecules B andA* (or the equivalentA and B*;
Fig. 3 and Table 2). Interestingly, the more minor interactions
within the asymmetric unit trimer between molecules A and C
and between molecules A and B sum to approximately the
same surface area as the B–C (or A–B*) interaction,
suggesting a stable trimer that might persist in solution. The
size of the B–C or A–B* buried surfaces is comparable to that
buried in the Gst-Sda–KinB complex (Table 2). Significantly,
the surfaces of interaction between molecules B and C and
between molecules B and A* both involve Phe25, which
projects from one face of the molecule (Fig. 2c, magenta and
pink molecules) and inserts into a hydrophobic pocket on the
other face of the partner molecule (Fig. 2c, light blue and blue
molecules). In fact, the two different head-to-tail arrange-
ments both house Phe25 in the same hydrophobic pocket
(lined by Ile10, Tyr13 and Phe14), but in a slightly different
research papers
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Table 2
Buried surface interfaces for each molecule as calculated by PISA
(Krissinel & Henrick, 2007).
Subunit 1 Subunit 2 Subunit 3 Contact area (A˚2)
Bsu-Sda chain B Bsu-Sda chain C — 571
Bsu-Sda chain B Bsu-Sda chain A* — 510
Bsu-Sda chain A Bsu-Sda chain C — 307
Bsu-Sda chain A Bsu-Sda chain B — 234
Bsu-Sda chain A Bsu-Sda chain B Bsu-Sda chain C 1112
Bsu-Sda chain B Bsu-Sda chain C Bsu-Sda chain A* 1081
Gst-KinB Gst-Sda — 649
Figure 4
Sda solution model fits to SAXS data. (a) Subunit A. (b) A–B–C–A*–B*–C* hexamer. (d) B–C dimer. (d) A–B* dimer. (e) A–B–C trimer. (f) B–C–A*
trimer. (g) B–C dimer with disordered residues modelled. (h) A–B–C trimer with disordered residues modelled. (i) Original NMR structure modelled as
a dimer. TheA,B and C subunits are coloured as in Fig. 3, mass-enhanced models are coloured blue and the NMR dimer is shown in orange. 2 values are
reported in the top right corner of each panel.
orientation in each case (Fig. 2c; compare the light blue and
blue molecules). This hydrophobic pocket is similar to the
pocket in the DHp domain of the Gst-KinB histidine kinase
(Fig. 2c; lined by residues Gly224, Phe225 and Leu228, and
shown as orange surface and sticks).
3.4. Solution state of Sda
The solution state of Bsu-Sda has been subject to different
interpretations; it was first described as a monomer based on
NMR and MALLS data (Rowland et al., 2004) and subse-
quently as a dimer based on SAXS data (Whitten et al., 2007).
In the case of the SAXS data the biophysical parameters [the
radius of gyration (Rg) and maximum linear dimension
(Dmax)] were inconsistent with a monomer model. We were
able to reasonably fit the SAXS data with dimer models
generated from the NMR structure whilst imposing a P2
symmetry constraint (the best 2 value reported was 1.08; see
Fig. 4i). This model has a minimal interaction surface between
the two molecules, with some steric clashes in this region. We
now have the opportunity to evaluate new monomer and
multimer models derived directly from the crystal structure.
Models evaluated included the Sda monomer (chain A), the
dimers A–B* and B–C, the trimers A–B–C (asymmetric unit)
and B–C–A*, the tetramer A–B–A*–
B* and the hexamer A–B–C–A*–B*–
C* (Fig. 3). The monomer, tetramer
and hexamer models do not fit the
data, with 2 values of 5.6, 4.79
and 19.3, respectively. Theoretical
monomer and hexamer scattering
profiles overlayed with the data are
shown in Figs. 4(a) and 4(b). The two
dimer models fit the data significantly
better but are still far from ideal fits,
with 2 values of 2.2 and 2.0 (Figs. 4c
and 4d, respectively). In contrast, the
trimer models fit the data best (Figs. 4e
and 4f), with 2 = 0.85 for the A–B–C
trimer (asymmetric unit) and 2 = 1.1
for the B–C–A* trimer. A statistical
significance test (F-test) comparing
these trimer 2 values indicates that the
difference between the fit of these
models to the data is significant
(p-value of 0.96), favouring the asym-
metric unit trimer model. Additionally,
in the A–B–C trimer model each
constituent Sda molecule makes inter-
molecular contacts with the other two
in the ensemble (this is not the case
with the B–C–A* trimer), suggesting
that such a species might be more
stable in solution.
The superposition of the A–B–C
trimer model onto the molecular
envelope generated from the SAXS
data using shape restoration is shown in Fig. 5. Interestingly,
the volume of the averaged dummy-atom reconstructions
output by DAMAVER (20 620 A˚3) for the SAXS data is near-
identical to that calculated for a trimer constructed of full-
length 48-residue monomers (20 820 A˚3). However, the trimer
model based on the crystal structure which best fits the scat-
tering data is missing approximately 25% of the total mass
owing to disorder. Attempts to include the missing mass in the
form of side chains and/or terminal residues were made for
various dimeric and trimeric states (examples are shown in
Figs. 4g and 4h), but the calculations performed using such
models assume that the added residues are rigid and none of
these augmented models resulted in a superior fit to the SAXS
data (2 = 1.45 and 3.29 for the dimer and trimer, respectively;
see Figs. 4g and 4h).
Sda is known to complex its target histidine kinases as a
monomer (Whitten et al., 2007; Bick et al., 2009), suggesting
that any larger complexes observed in vitromust be capable of
dissociation. In order to address the possibility that multiple
Sda species exist in equilibrium, fits to the scattering data were
calculated with various combinations of monomer, dimer,
trimer, tetramer and hexamer using OLIGOMER (Table 3).
OLIGOMER calculates the mass fraction of a particular
species in solution assuming that multiple species are contri-
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Figure 5
Sda trimer A–B–C positioned inside a dummy-atom enveloped generated by DAMMIN (Svergun,
1999) and DAMAVER (Volkov & Svergun, 2003) to model the SAXS data.
Table 3
Modelling the SAXS data with a mixture of different oligomers of Sda.
The values are the calculated fractions of each component and the overall fit for each calculation. Results
including trimer models are given in bold. Ensemble components (with reference to Fig. 3): monomer = A;
dimer = B–C; trimer = A–B–C; hexamer = A–B–C–A*–B*–C*. Calculations involving all combinations of
ensembles including the tetramer A–B–A*–B* were also performed but have been omitted for simplicity.
The results for these tetramer-containing ensembles were the same: those including trimers yielded 2
values close to 1 with high fidelities but with little or no contribution from the tetramer species; those
without trimers yielded low fidelity values with little contribution from the tetramer component.
Fractions  error
Calc. Ensemble Monomer Dimer Trimer Hexamer 2 Fidelity
1 Mon Dim 0.19  0.05 0.81  0.03 1.93 3.9  1015
2 Mon Tri 0.01  0.08 0.99  0.03 0.85 0.96
3 Mon Hex 0.88  0.01 0.12  0.00 1.00 0.50
4 Dim Tri 0.01  0.09 0.99  0.06 0.85 0.96
5 Dim Hex 0.95  0.02 0.05  0.01 1.77 1.1  1011
6 Tri Hex 1.00  0.00 0.00  0.00 0.85 0.96
7 Mon Dim Tri 0.01  0.08 0.00  0.09 0.99  0.06 0.85 0.96
8 Mon Dim Hex 0.81  0.06 0.08  0.05 0.11  0.01 0.99 0.56
9 Mon Tri Hex 0.08  0.26 0.91  0.16 0.01  0.04 0.85 0.96
10 Dim Tri Hex 0.01  0.09 0.99  0.06 0.00  0.00 0.85 0.96
11 Mon Dim Tri Hex 0.08  0.26 0.00  0.09 0.91  0.16 0.01  0.04 0.85 0.96
buting to the scattering. The program also calculates the 2 of
the resultant fit to the data, as well as a fidelity value
describing the probability that the fits are statistically consis-
tent with the data. The best 2 and fidelity values are obtained
in calculations 2, 4, 6, 7 and 9–11, all of which include the A–
B–C trimer model (Table 3, in bold). In each case the trimer is
calculated to be the dominant species in solution. The
OLIGOMER calculation that samples only monomer and
dimer species is incapable of reasonably fitting the data
(calculation 1). Calculations 3, 5 and 8, which also lack the
trimer model, output reasonable 2 values but are less likely to
be correct according to the fidelity values. Hence, these results
indicate that the A–B–C trimer found in the asymmetric unit
(possibly in equilibrium with a small amount of monomer and
dimer) best fits the SAXS data and is the most likely oligo-
meric state of Sda in solution at the concentration investigated
by SAXS.
In order to reconcile this conclusion with the MALLS data
reported with the NMR structure, we performed MALLS on
Sda eluting from a gel-filtration column using essentially the
same instrumentation and buffer conditions as originally
reported (50 mM sodium phosphate pH 7.9, 300 mM NaCl,
0.02% NaN3 pH 7.9; Rowland et al., 2004) and under the
buffer conditions used for the SAXS measurement (50 mM
Tris pH 8.5, 50 mM NaCl; Whitten et al., 2007). At the Sda
concentrations we investigated using MALLS, the Sda
preparation behaved identically in both buffer conditions,
although the molecular-weight estimates determined for the
eluting peaks showed a concentration dependence. The
expected molecular weights for the trimeric, dimeric and
monomeric states of Sda are 17.1, 11.4 and 5.7 kDa, respec-
tively. At (high) concentrations approaching the refractive-
index limit of the instrument, the Sda elution peak returned
molecular-weight estimates of 9.3  0.1 kDa (maximum
peak concentration of 0.9 mg ml1 ’ 160 mM; Fig. 6, red
trace and data points). At (low) concentrations approaching
the light-scattering detection limit, the Sda peak eluted frac-
tionally later, returning a molecular-weight estimate of7.2
0.4 kDa (maximum peak concentration of 0.1 mg ml1 ’
20 mM; Fig. 6, magenta trace and data points). Both high- and
low-concentration Sda peaks are asymmetric in shape
(noticeably steeper on the earlier eluting side), which is
indicative of a polydisperse population of molecules within the
peak. This is also evidenced by the ‘frown-like’ distribution of
the molecular-weight estimates, which are lower on either side
of the peak maximum corresponding to lower local protein
concentrations. The behaviour of the A280 and molecular-
weight estimate profiles of the Sda samples contrast with those
from bovine pancreatic trypsin inhibitor (BPTI), a 6.5 kDa
protein that does not oligomerize, examined under the same
conditions (Fig. 6, blue trace and scatter points). At the higher
concentration of Sda investigated by MALLS the eluting peak
is probably populated by a greater proportion of dimers (and
maybe trimers) than at the lower concentration. These data
clearly indicate that the oligomeric state of Sda is concentra-
tion dependent, that the equilibrium constant for these
oligomerizations are in the micromolar range and that the
rates of association and dissociation for the oligomerizations
are such that monomeric and multimeric species are not
partitioned by the gel-filtration column. It should be noted
that the concentrations examined by MALLS are considerably
lower than those used for the SAXS analysis or for NMR
(>5 mg ml1 ’ 1 mM), where a greater proportion of the
trimer species, which is an excellent fit to the SAXS data,
would be expected. Hence, it is probable that the apparent
contradiction noted between the molecular-weight estimates
returned by SAXS and MALLS was merely a reflection of
sample concentration.
It seems unlikely that the sample used for NMR studies
could have been a tight trimer as this would have led to
intermolecular NOEs being mistakenly interpreted as intra-
molecular NOEs, which would have inevitably introduced
errors in the structure. However, if the trimer was in equili-
brium with smaller species, as suggested by the new MALLS
data (discussed above), and the exchange between the two (or
more) states occurs on the so-called intermediate exchange
timescale, the intermolecular NOEs could have been severely
broadened and become essentially invisible relative to the
monomer signal.
3.5. Caveats for SAXS interpretation of small proteins
The SAXS data are clearly inconsistent with the monomeric
model of Sda (Fig. 4a). The scattering experiment was re-
peated under identical solution conditions to the NMR
experiment (pH, ionic strength and concentration), with no
observable change in the data. Our analysis of the forward
scattering intensity [I(0)] appeared to be consistent with a
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Figure 6
MALLS-derived molecular weights for Sda eluting from a gel-filtration
column at high (red) and low (magenta) relative concentrations. The solid
lines correspond toA280 traces, whilst the scatter plots indicate molecular-
weight estimates calculated for different parts of the elution profile. Data
for bovine pancreatic trypsin inhibitor (BPTI; monomer at 6.5 kDa) run
under identical conditions are included for reference (blue trace and
scatter points). The plots have been scaled for clarity: 0.7 for BPTI and
5 for low-concentration Sda. The profiles and relative elution times for
the three samples were identical in high-salt and low-salt buffers (detailed
in x2.6).
dimeric species (Whitten et al., 2007). However, the I(0)-
derived mass of a protein in solution is dependent on an
accurate estimate of concentration, as well as on assumptions
that the partial specific volume is comparable to a known
protein standard (in this case lysozyme). Sda has a very low
molar absorption coefficient as it contains only one tyrosine
residue and no tryptophan residues ("280 = 1490M1 cm1),
making accurate concentration determination by this method
highly susceptible to overestimation owing to minor contam-
ination with more strongly absorbing species. The structure of
Sda also reveals a large disordered component that lacks a
significant hydrophobic interior. Hence, the partial specific
volume might be expected to deviate significantly from that of
more typical globular proteins (such as lysozyme). It is likely
that both concentration overestimation and an incorrect
partial specific volume assumption resulted in our misinter-
pretation of the I(0) data.
Our current model for the solution state of Sda, consistent
with all the biophysical techniques employed, is that at high
concentration the molecule oligomerizes into a weakly asso-
ciated trimer in equilibrium with low concentrations of
dimeric and monomeric species. Whilst the SAXS sample was
one of high concentration and purity, the concentration
dependence noted for the oligomeric state (new MALLS
data) is consistent with the expectation that in vivo Sda
functions as a monomer.
4. Concluding remarks
The availability of the crystal structure of Sda, which on its
own yielded little clue as to the solution state of the molecule,
has unwittingly provided a model template which allows a
reappraisal of previous biophysical results, the analysis of
which was likely to have been misled by issues of concentra-
tion determination and intrinsic flexibility. This study there-
fore highlights the caution that must be exercised during
interpretation of biophysical data, especially when applied to
small proteins that fall outside the usual parameters of
detectability and rigidity, as well as highlighting the value of
combining complementary techniques to probe the solution
behaviour of biological macromolecules.
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